Archies Ltd. dominates the greeting cards business with a 50% market share in the organized sector. The company's greatest strength is its retail reach. The company has 475 plus franchise stores and around 40 owned stores. Apart from greeting cards, ... More
Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More
ARCHIES | COLGATE | ARCHIES/ COLGATE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -4.2 | 47.3 | - | View Chart |
P/BV | x | 0.4 | 28.6 | 1.3% | View Chart |
Dividend Yield | % | 0.0 | 1.5 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ARCHIES Mar-19 |
COLGATE Mar-19 |
ARCHIES/ COLGATE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 47 | 1,365 | 3.4% | |
Low | Rs | 21 | 1,020 | 2.0% | |
Sales per share (Unadj.) | Rs | 47.0 | 164.1 | 28.6% | |
Earnings per share (Unadj.) | Rs | 0.2 | 28.5 | 0.8% | |
Cash flow per share (Unadj.) | Rs | 1.3 | 34.4 | 3.7% | |
Dividends per share (Unadj.) | Rs | 0 | 23.00 | 0.0% | |
Dividend yield (eoy) | % | 0 | 1.9 | 0.0% | |
Book value per share (Unadj.) | Rs | 34.9 | 53.2 | 65.7% | |
Shares outstanding (eoy) | m | 33.78 | 271.99 | 12.4% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.7 | 7.3 | 9.8% | |
Avg P/E ratio | x | 155.0 | 41.8 | 370.6% | |
P/CF ratio (eoy) | x | 26.3 | 34.7 | 75.7% | |
Price / Book Value ratio | x | 1.0 | 22.4 | 4.3% | |
Dividend payout | % | 0 | 80.7 | 0.0% | |
Avg Mkt Cap | Rs m | 1,132 | 324,389 | 0.3% | |
No. of employees | `000 | 1.3 | 2.3 | 55.4% | |
Total wages/salary | Rs m | 319 | 2,959 | 10.8% | |
Avg. sales/employee | Rs Th | 1,242.2 | 19,359.8 | 6.4% | |
Avg. wages/employee | Rs Th | 249.6 | 1,283.7 | 19.4% | |
Avg. net profit/employee | Rs Th | 5.7 | 3,364.7 | 0.2% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,587 | 44,624 | 3.6% | |
Other income | Rs m | 26 | 377 | 7.0% | |
Total revenues | Rs m | 1,614 | 45,001 | 3.6% | |
Gross profit | Rs m | 44 | 12,361 | 0.4% | |
Depreciation | Rs m | 36 | 1,592 | 2.2% | |
Interest | Rs m | 27 | 25 | 108.0% | |
Profit before tax | Rs m | 7 | 11,121 | 0.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 305 | 0.0% | |
Tax | Rs m | 0 | 3,670 | 0.0% | |
Profit after tax | Rs m | 7 | 7,756 | 0.1% | |
Gross profit margin | % | 2.8 | 27.7 | 10.0% | |
Effective tax rate | % | 0 | 33.0 | 0.0% | |
Net profit margin | % | 0.5 | 17.4 | 2.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 812 | 10,102 | 8.0% | |
Current liabilities | Rs m | 352 | 10,511 | 3.4% | |
Net working cap to sales | % | 28.9 | -0.9 | -3,153.2% | |
Current ratio | x | 2.3 | 1.0 | 239.6% | |
Inventory Days | Days | 117 | 20 | 575.2% | |
Debtors Days | Days | 44 | 17 | 255.9% | |
Net fixed assets | Rs m | 755 | 13,896 | 5.4% | |
Share capital | Rs m | 68 | 272 | 24.9% | |
"Free" reserves | Rs m | 1,113 | 14,196 | 7.8% | |
Net worth | Rs m | 1,180 | 14,468 | 8.2% | |
Long term debt | Rs m | 0 | 777 | 0.0% | |
Total assets | Rs m | 1,685 | 26,265 | 6.4% | |
Interest coverage | x | 1.3 | 445.8 | 0.3% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.9 | 1.7 | 55.5% | |
Return on assets | % | 2.0 | 29.6 | 6.9% | |
Return on equity | % | 0.6 | 53.6 | 1.2% | |
Return on capital | % | 2.9 | 75.1 | 3.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 17 | 2,007 | 0.9% | |
Fx outflow | Rs m | 207 | 7,191 | 2.9% | |
Net fx | Rs m | -190 | -5,184 | 3.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 72 | 9,830 | 0.7% | |
From Investments | Rs m | -46 | -957 | 4.8% | |
From Financial Activity | Rs m | -18 | -8,147 | 0.2% | |
Net Cashflow | Rs m | 9 | 726 | 1.2% |
Indian Promoters | % | 60.6 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 51.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 7.0 | 10.0% | |
FIIs | % | 0.0 | 20.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 38.8 | 22.1 | 175.6% | |
Shareholders | 15,057 | 131,569 | 11.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ARCHIES With: GODREJ CONSUMER MARICO K.S.OILS LINC PEN & PLASTICS GILLETTE INDIA
Compare ARCHIES With: UNILEVER PLC. (UK) P&G (US) HYPERMARCAS (Brazil)
Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 34 points, up 0.1% at 48,844 levels.
For the quarter ended September 2020, COLGATE has posted a net profit of Rs 3 bn (up 12.3% YoY). Sales on the other hand came in at Rs 13 bn (up 6.0% YoY). Read on for a complete analysis of COLGATE's quarterly results.
For the quarter ended June 2020, COLGATE has posted a net profit of Rs 2 bn (up 17.2% YoY). Sales on the other hand came in at Rs 10 bn (down 4.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.
For the quarter ended March 2020, COLGATE has posted a net profit of Rs 2 bn (up 3.3% YoY). Sales on the other hand came in at Rs 11 bn (down 7.1% YoY). Read on for a complete analysis of COLGATE's quarterly results.
For the quarter ended December 2019, COLGATE has posted a net profit of Rs 2 bn (up 3.6% YoY). Sales on the other hand came in at Rs 11 bn (up 4.3% YoY). Read on for a complete analysis of COLGATE's quarterly results.
For the quarter ended September 2019, COLGATE has posted a net profit of Rs 2 bn (up 24.3% YoY). Sales on the other hand came in at Rs 12 bn (up 3.9% YoY). Read on for a complete analysis of COLGATE's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.
Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.
More